Two Studies Link GLP-1 Use to Lower Breast Cancer Risk Will Pass June 25, 2026

https://www.medscape.com/viewarticle/two-studies-link-glp-1-use-lower-breast-cancer-risk-2026a1000ln4?src= GLP-1 receptor agonists (GLP-1 RAs) are associated with reduced incidence of breast cancer among women with overweight or obesity, according to two observational studies. One found that GLP-1 RA users had a roughly 30% lower incidence of breast cancer than was seen in matched nonusers. The smaller of the two, which followed more than 80,000 women at high risk for breast cancer, found a more modest 16% reduction.